P20GM152326
Project Grant
Overview
Grant Description
Nebraska Center for Heart and Vascular Research - Project Title: Nebraska Center for Heart and Vascular Research
Project Summary: Overall Center Organization and Management Plan
Heart and Vascular Diseases (HVD) are the leading cause of death and hospitalization in the United States, Nebraska included.
The goal of the Nebraska Center for Heart and Vascular Research (CHVR) is to build the physical and intellectual resources at the University of Nebraska Medical Center (UNMC) to propel the ability of our faculty to conduct research that drives the heart and vascular disease (HVD) field forward.
Our center has exceptional institutional support, is well-aligned with UNMC’s areas of research emphasis, and we have an outstanding baseline cadre of investigators with expertise in HVD disease.
The main objective of this Phase I COBRE is to develop a center that promotes and supports excellence in HVD research through the development of early career researchers, promotes collaborative research that is critical to solving complex research problems, and expands support for all HVD research with cutting edge infrastructure and mentoring activities.
We have selected research project leaders with research projects that have a strong connection to the focus of the COBRE and are poised to become independent researchers.
The COBRE will maximize the ability of the center to boost HVD research at UNMC, enhance faculty research trajectories, mentor early career investigators to productive research careers, and reduce barriers to research to drive discovery.
The center has brought together the full range of cutting-edge expertise needed to accomplish our mission and assembled a strong mentoring program that will train mentors in best practices.
To catalyze cutting edge HVD research the center will support existing resources and grow new ones like the proposed Bioassay Core focused on the targeted examination of proteins.
With these goals and the Phase I COBRE funding, the center will support the infrastructure required for cutting-edge HVD research, increase the number of funded researchers, and total HVD funding to promote a reputation and culture of excellence in HVD research that can improve patient outcomes and reduce HVD health disparities.
Project Summary: Overall Center Organization and Management Plan
Heart and Vascular Diseases (HVD) are the leading cause of death and hospitalization in the United States, Nebraska included.
The goal of the Nebraska Center for Heart and Vascular Research (CHVR) is to build the physical and intellectual resources at the University of Nebraska Medical Center (UNMC) to propel the ability of our faculty to conduct research that drives the heart and vascular disease (HVD) field forward.
Our center has exceptional institutional support, is well-aligned with UNMC’s areas of research emphasis, and we have an outstanding baseline cadre of investigators with expertise in HVD disease.
The main objective of this Phase I COBRE is to develop a center that promotes and supports excellence in HVD research through the development of early career researchers, promotes collaborative research that is critical to solving complex research problems, and expands support for all HVD research with cutting edge infrastructure and mentoring activities.
We have selected research project leaders with research projects that have a strong connection to the focus of the COBRE and are poised to become independent researchers.
The COBRE will maximize the ability of the center to boost HVD research at UNMC, enhance faculty research trajectories, mentor early career investigators to productive research careers, and reduce barriers to research to drive discovery.
The center has brought together the full range of cutting-edge expertise needed to accomplish our mission and assembled a strong mentoring program that will train mentors in best practices.
To catalyze cutting edge HVD research the center will support existing resources and grow new ones like the proposed Bioassay Core focused on the targeted examination of proteins.
With these goals and the Phase I COBRE funding, the center will support the infrastructure required for cutting-edge HVD research, increase the number of funded researchers, and total HVD funding to promote a reputation and culture of excellence in HVD research that can improve patient outcomes and reduce HVD health disparities.
Funding Goals
THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (NIGMS) SUPPORTS BASIC RESEARCH THAT INCREASES OUR UNDERSTANDING OF BIOLOGICAL PROCESSES AND LAYS THE FOUNDATION FOR ADVANCES IN DISEASE DIAGNOSIS, TREATMENT, AND PREVENTION. NIGMS ALSO SUPPORTS RESEARCH IN SPECIFIC CLINICAL AREAS THAT AFFECT MULTIPLE ORGAN SYSTEMS: ANESTHESIOLOGY AND PERI-OPERATIVE PAIN, CLINICAL PHARMACOLOGY ?COMMON TO MULTIPLE DRUGS AND TREATMENTS, AND INJURY, CRITICAL ILLNESS, SEPSIS, AND WOUND HEALING.? NIGMS-FUNDED SCIENTISTS INVESTIGATE HOW LIVING SYSTEMS WORK AT A RANGE OF LEVELSFROM MOLECULES AND CELLS TO TISSUES AND ORGANSIN RESEARCH ORGANISMS, HUMANS, AND POPULATIONS. ADDITIONALLY, TO ENSURE THE VITALITY AND CONTINUED PRODUCTIVITY OF THE RESEARCH ENTERPRISE, NIGMS PROVIDES LEADERSHIP IN SUPPORTING THE TRAINING OF THE NEXT GENERATION OF SCIENTISTS, ENHANCING THE DIVERSITY OF THE SCIENTIFIC WORKFORCE, AND DEVELOPING RESEARCH CAPACITY THROUGHOUT THE COUNTRY.
Grant Program (CFDA)
Funding Agency
Place of Performance
Nebraska
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 100% from $2,598,417 to $5,207,382.
Board Of Regents Of The University Of Nebraska was awarded
Nebraska Heart Vascular Research: Advancing HVD Research Excellence
Project Grant P20GM152326
worth $5,207,382
from National Heart Lung and Blood Institute in January 2024 with work to be completed primarily in Nebraska United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.837 Cardiovascular Diseases Research.
The Project Grant was awarded through grant opportunity Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional).
Status
(Ongoing)
Last Modified 9/24/25
Period of Performance
1/1/24
Start Date
12/31/28
End Date
Funding Split
$5.2M
Federal Obligation
$0.0
Non-Federal Obligation
$5.2M
Total Obligated
Activity Timeline
Transaction History
Modifications to P20GM152326
Additional Detail
Award ID FAIN
P20GM152326
SAI Number
P20GM152326-1975535545
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NS00 NIH National Institute of General Medical Sciences
Funding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Awardee UEI
G15AG3BLLMH4
Awardee CAGE
1PPD6
Performance District
NE-90
Senators
Deb Fischer
Modified: 9/24/25